USD
Reduce targetBefore 20.1%Target 15%
Cash allocation. No separate rationale was supplied.
Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Sep 18, 2026, 8:13 AM EDT
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
I am retaining the established financials sleeve, adding CB for insurer-quality diversification, and holding 15% cash. The mix favors inexpensive underwriting earnings, rate-sensitive investment-income exposure, bank and payment rails, and exchange income; cash is retained because the rate cycle can move the whole sector before individual balance sheets can prove their resilience.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
Cash allocation. No separate rationale was supplied.
I expect TRV’s fixed-income portfolio to benefit from the changed rate backdrop, supporting earnings alongside its positive price trend. Supplied coverage cites expected after-tax fixed-income investment income of about $840M in Q3 and $870M in Q4; return20 was 4.77%. I’m wrong if investment income or price strength reverses materially.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect CME’s exchange infrastructure and cash dividend to diversify the balance-sheet-sensitive lenders and insurers while preserving income. Its trailing cash dividend yield was 4.17%, and return20 was 1.58%. I’m wrong if the positive price evidence fades and the income stream no longer offsets the valuation and cycle risk.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect ACGL’s low earnings multiple to provide a margin of safety through the underwriting cycle, while the recent pullback avoids paying for momentum. TTM EPS was 12.67 and P/E 7.63, while return20 was -1.86%. I’m wrong if earnings power erodes and the valuation gap fails to cushion it.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: high · Horizon: quarters
I expect JPM to remain a core diversified-bank holding because its earnings base supports measured exposure to the rate cycle after a recent retracement. TTM diluted EPS was 23.95 and P/E was 14.58; return20 was -2.23%. I’m wrong if the pullback signals weaker earnings capacity rather than a better entry balance.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect CB to add steadier property-and-casualty exposure because its share price has held near its short-term trend despite a fuller valuation. Return20 was 0.29% and the 20-session average was 340.99; TTM P/E was 14.54. I’m wrong if that relative resilience breaks without earnings support.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect V to provide payment-rail diversification from credit and underwriting cycles, with modest positive price evidence supporting a balanced allocation. Return20 was 1.20%, while the latest stored close was below its 20-session average of 374.91. I’m wrong if that trend deterioration persists and neutral earnings-estimate evidence fails to improve.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: quarters
I expect WFC to offer value-oriented bank exposure as its recent price action remains constructive and its earnings multiple stays moderate. TTM diluted EPS was 6.86, P/E was 12.67, and dividend yield was 2.13%; return20 was 1.11%. I’m wrong if rate-cycle pressure undermines earnings and reverses that resilience.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: months
I expect PGR’s underwriting execution and cash yield to support total return without requiring a momentum chase. The supplied coverage cites an 87.3% combined ratio, while TTM P/E was 10.64 and trailing dividend yield was 6.43%. I’m wrong if underwriting performance weakens and the yield does not compensate.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: months
I expect ALL’s compressed valuation to compensate for recent price weakness if underwriting earnings remain durable. Its TTM diluted EPS was 50.08 and P/E was 5.04, while the 20-session return was -2.90%. I’m wrong if the earnings base contracts enough that the low multiple proves cyclical rather than protective.
Recorded Sep 18, 2026, 8:13 AM EDT · Conviction: medium · Horizon: months
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Monitor for mandate drift. Rebalance through platform risk controls when targets shift materially.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Financial Strength cycle started by scheduled.
Financial Strength produced a canonical target-weight decision.
Created sell proposal for ALL-USD.
Risk engine approved proposal 01M2T76QTGFM91KM8ANPHJ8068.
Queued sell order for ALL-USD for MOO execution.
Financial Strength cycle completed with status pending_fill.
Assumed MOO sell fill for ALL-USD at the verified session open.
Simulated sell fill for ALL-USD at the verified MOO session open.
Recorded balanced ledger entries for assumed MOO fill.
Financial Strength valuation snapshot recorded for agent_cycle_run 01M2T74X97RGJS702S3Y9HBVNY.